Thomas J Schnitzer

Grants

Grants per year 2002 2004 2005 2006 2007 2008 2009 2010 2012 2015 2016 2019 2020 2025

• 17 Active
• 85 Finished

Grants per year

Search results

• Finished

  Prot# PN400-307: Randomized, Double-Blind, Parallel Group, Placebo-Controlled Multi-Center Study Evaluating the Efficacy of PN 400 BID and Celecoxib 200 mg QD in Patients with Osteoarthritis of the Knee.

  Schnitzer, T. J.

  Kendle International Inc., POZEN Inc.

  7/17/08 → 7/17/11

  Project: Research project

• Proprioception and Joint Stability Across Planes in Knee Asteoarthritis

  Dhaher, Y. Y. & Schnitzer, T. J.

  Arthritis Foundation

  7/1/08 → 6/30/10

  Project: Research project

• Prot# A6171016: A Long-Term, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Radiographic Study to Investigate the Safety and Efficacy of Orally Administered SD-6010 in Subjects with Symptomatic Osteoarthritis of the Knee

  Schnitzer, T. J.

  ICON Clinical Research, LLC, Pfizer Inc.

  4/10/08 → 4/10/11

  Project: Research project

• Prot# 2007008: A Non-Inferiority Comparison of 35mg Delayed-Release Risedronate, Administered Once-Weekly Either Before or After Breakfast, and 5mg Immediate-Release Risedronate, Administered Once-Daily Before Breakfast, in the Treatment of Postmenopausal

  Schnitzer, T. J.

  Parexel, Procter & Gamble Company

  1/3/08 → 1/3/11

  Project: Research project

• Prot# TD-07-14: The Efficacy and Safety of TDS-943 in the Treatment of Osteoarthritis of the Knee: Pivotal Study II

  Schnitzer, T. J.

  Wyeth

  12/12/07 → 12/12/10

  Project: Research project

• Prot# 3175A1-202-WW: A Multicenter, Randomized, Double-Blind Comparison of 4 Dose Regimens of PLA-695, Naproxen, and Placebo Administered Daily for 6 Weeks in Subjects with Active Osteoarthritis of the Knee

  Schnitzer, T. J.

  Wyeth

  5/9/07 → 5/9/10

  Project: Research project

• Prot# CCOX189A2428: A 4-Wk, Mltcntr, Rndmzd, Dbl-Blind, Dbl-Dummy, Parallel Grp Ambulatory Blood Pressure Monitoring Study to Demonstrate that Trtmnt w/Lumiracoxib 100mg o.d. Results in an Improved 24-Hr Blood Pressure Profile

  Schnitzer, T. J.

  Novartis Pharmaceuticals Corporation

  3/14/07 → 6/14/07

  Project: Research project

• Prot# 3151A4-330-US: A 6-Month Open-Label Extension Study of the Long-Term Safety of DVS SR in Outpatients with Fibromyalgia Syndrome

  Schnitzer, T. J.

  Wyeth

  2/13/07 → 5/2/07

  Project: Research project

• Prot# F1J-MC-HMEP: Duloxetine 60 to 120mg versus Placebo in the Treatment of Patients with Osteoarthritis Knee Pain

  Schnitzer, T. J.

  Lilly Research Laboratories

  1/19/07 → 9/27/09

  Project: Research project

• Prot: Double-Blind Brain Imaging of Lidoderm Therapy vs. Placebo for Chronic Back Pain (CBP)

  Apkarian, A. & Schnitzer, T. J.

  Endo Pharmaceuticals Inc

  10/30/06 → 10/7/10

  Project: Research project

• Prot# F06-101: Collection of Serum Samples from Subjects with Multiple Sclerosis and Psoriasis for Assay Development

  Schnitzer, T. J.

  Abbott Laboratories

  8/23/06 → 8/23/07

  Project: Research project

• Prot# 3151A4-327-US: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adaptive-Design, Efficacy, Safety and Tolerability Study of 4 Fixed Oral Doses of DVS SR in Adult Outpatients with Fibromyalgia Syndrome

  Schnitzer, T. J.

  Wyeth

  8/4/06 → 10/13/08

  Project: Research project

• Pilot Trial of Effects of Intra-Articular Synvisc Therapy on Cartilage Determined by dGEMRIC in Patients with OA of the Knee

  Schnitzer, T. J.

  NorthShore University HealthSystem Research Institute, Genzyme Corporation

  7/1/06 → 6/30/09

  Project: Research project

• Prot# HCT 3012-X-301: A Phs 3 Stdy of the Analgesic Efficacy & Sfty of HCT 3012: A Parallel, Randomized, Double-Blind, 13-Wk, Placebo-& Naproxen-Controlled, Multicenter Study of HCT 3012 (375 mg bid & 750 mg bid) in Ptnts w/Osteoarthritis of the Knee

  Schnitzer, T. J.

  PRA Health Sciences, NicOx S.A.

  5/3/06 → 12/21/06

  Project: Research project

• Prot# CZOL446H2301E1: A 3-Year, Double-Blind Extension to CZOL446H2301 to Evaluate the Long Term Safety and Efficacy of Zoledronic Acid in the Treatment of Osteoporosis in Post-Menopausal Women Taking Calcium and Vitamin D

  Schnitzer, T. J.

  Novartis Pharmaceuticals Corporation

  10/7/05 → 3/31/08

  Project: Research project

• Prot# CXA30007: A Phs III,12-Wk,Mltcntr,Dbl-Blind,Dbl-Dummy,Randomised,Placebo-&Active Comparator-Controlled,Parallel Group Study to Investigate the Efficacy&Safety of GW406381 1mg,5mg,10mg,25mg&50mg Admin Orally 1x Daily,in Adults w/Osteoar

  Schnitzer, T. J.

  GlaxoSmithKline plc

  8/8/05 → 10/30/06

  Project: Research project

• Prot# WA18063B: A Rndmzd, Dbl-Blnd, Plcb-Cntrlld, Prllel Grp Stdy of the Sfty & Rdctn of Sgn & Symptms Drng Trtmnt w/ MRA vs Plcb, In Cmbntn w/ Trdtnl DMARD Thrpy in Ptnts w/ Mdrt to Svre Actv Rhumtd Arthrts & an indqt rspns to crrnt DMARD Thrpy

  Ruderman, E. M. & Schnitzer, T. J.

  Hoffman-La Roche, Inc.

  7/11/05 → 9/10/10

  Project: Research project

• Prot# AVS00103: A Multicenter, Parallel, Double-Blind, Blinded Evaluator, Randomized Comparison of the Efficacy and Safety of an Alternate Viscosupplement (AVS-beta) to Methylprednisolone Acetate in Patients with Symptomatic Osteoarthritis of the Knee

  Schnitzer, T. J.

  Genzyme Corporation

  6/23/05 → 6/20/08

  Project: Research project

• Prot# A9001140: A Longitudinal Study of Osteoarthritis (OA) Disease Progression Measured by MRI, dGEMRIC, and Radiography

  Schnitzer, T. J.

  NorthShore University HealthSystem Research Institute, Pfizer Inc.

  5/5/05 → 2/29/08

  Project: Research project

• Prot# CZOL446H2315: A Multicenter, Randomized, Double-Blind, Double-Dummy Study to Determine the Rapidity of Onset of Zoledronic Acid Compared to Alendronate in Post-Menopausal Women with Moderate/Severe Osteopenia or Osteoporosis

  Schnitzer, T. J.

  Parexel, Novartis Pharmaceuticals Corporation

  2/25/05 → 5/25/05

  Project: Research project

• Prot# CZOL446H2315: A Multicenter, Randomized, Double-Blind, Double-Dummy Study to Determine the Rapidity of Onset of Zoledronic Acid Compared to Alendronate in Post-Menopausal Women with Moderate/Severe Osteopenia or Osteoporosis

  Schnitzer, T. J.

  Parexel, Novartis Pharmaceuticals Corporation

  2/25/05 → 5/25/05

  Project: Research project

• Prot# CCOX189A2367: A 13-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Group Trial of Lumiracoxib (COX189) 100mg o.d. in Patients with Primary Hip Osteoarthritis Using Celecoxib (200mg o.d.) as a Positive Control

  Schnitzer, T. J.

  Novartis Pharmaceuticals Corporation

  10/1/04 → 3/31/07

  Project: Research project

• Prot#211-00/FOS 530: Rndmzd, Dbl-Blind, Dbl-Dummy, Prll-Grp, Mlticntr Stdy to Eval & Comp Effects of 1x Wkly Alendronate & Risedronate on Bone Mineral Density in Postmenopausal Women w/Osteoporosis (FACT - FOSAMAX® ACTONEL® Comparison Trial)

  Schnitzer, T. J.

  NorthShore University HealthSystem Research Institute, Merck & Co., Inc.

  8/23/04 → 12/31/05

  Project: Research project

• Prot# CZOL446M2308: Randomized, Multicenter, Double-Blind, Double-Dummy, Parallel Group Study to Determine the Efficacy & Safety of Intravenous Zoledronic Acid 5mg Annually Compared to Oral Alendronate 70mg Weekly for the Treatment of Osteoporosis in Men

  Schnitzer, T. J.

  Parexel, Novartis Pharmaceuticals Corporation

  7/2/04 → 6/20/08

  Project: Research project

• Prot# CZOL446H2315: A Multicenter, Randomized, Double-Blind, Double-Dummy Study to Determine the Rapidity of Onset of Zoledronic Acid Compared to Alendronate in Post-Menopausal Women with Moderate/Severe Osteopenia or Osteoporosis

  Schnitzer, T. J.

  Parexel, Novartis Pharmaceuticals Corporation

  4/15/04 → 4/27/07

  Project: Research project